0001104659-19-048436.txt : 20190903 0001104659-19-048436.hdr.sgml : 20190903 20190903160429 ACCESSION NUMBER: 0001104659-19-048436 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190830 FILED AS OF DATE: 20190903 DATE AS OF CHANGE: 20190903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Broom Colin MD CENTRAL INDEX KEY: 0001289946 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 191072159 MAIL ADDRESS: STREET 1: 119 FRINGETREE DRIVE CITY: WEST CHESTER STATE: PA ZIP: 19380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 a4.xml 4 X0306 4 2019-08-30 0 0001641640 Nabriva Therapeutics plc NBRV 0001289946 Broom Colin MD 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406 1 0 0 0 Ordinary Shares 2019-08-30 4 P 0 10177 2.0309 A 208750 D The reporting person's purchase of ordinary shares of Nabriva Therapeutics plc (the "Issuer") reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 10,177 shares, with the reporting person's sale of 10,177 ordinary shares at a price of $2.07 per share on August 21, 2019. The reporting person has agreed to pay to the Issuer $397.93, representing the full amount of the profit realized in connection with the short-swing transaction. This amount represents the reporting person's total holdings of ordinary shares of the Issuer, including 72,849 ordinary shares formerly held indirectly by the reporting person in a grantor retained annuity trust. The grantor retained annuity trust has been terminated and the ordinary shares have been returned to the direct ownership of the reporting person. /s/ Robert Crotty, by power of attorney 2019-09-03